PerkinElmer Completes $600M Caliper Acquisition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today completed its acquisition of Caliper Life Sciences for $10.50 per share, valuing the deal at around $600 million.

The purchase, announced in September, provides PerkinElmer with Caliper's portfolio of imaging, microfluidics, automation, and sample preparation platforms and technologies and is expected to extend PerkinElmer's reach into the life sciences research space.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.